Approvals/TGA/SEQUASE XR quetiapine (as fumarate) 150 mg modified release tablet blister pack

Approved

STANDARD

SEQUASE XR quetiapine (as fumarate) 150 mg modified release tablet blister pack

Luye Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 763fe301ee6f57e1
Product Name: SEQUASE XR quetiapine (as fumarate) 150 mg modified release tablet blister pack
Artg Id: 212504
Artg Name: SEQUASE XR quetiapine (as fumarate) 150 mg modified release tablet blister pack
Sponsor: Luye Pharma Australia Pty Ltd
Company Detail Path: /organization/luye-pharma-australia-pty-ltd
Artg Date: 2014-07-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/848741e4ac2cd81dabf05730bd31f602.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/84fd469195d9e48075f2625f8f94f5a9.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

763fe301ee6f57e1

Type

Standard